Allworth Financial’s Chemours CC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $51.2K | Sell |
2,494
-88
| -3% | -$2.02K | ﹤0.01% | 2463 |
|
|
2026
Q1 | $56.9K | Buy |
2,582
+608
| +31% | +$10.6K | ﹤0.01% | 2222 |
|
|
2025
Q4 | $23.3K | Buy |
1,974
+365
| +23% | +$4.69K | ﹤0.01% | 2708 |
|
|
2025
Q3 | $25.5K | Buy |
1,609
+83
| +5% | +$1.2K | ﹤0.01% | 2546 |
|
|
2025
Q2 | $17.5K | Sell |
1,526
-407
| -21% | -$4.59K | ﹤0.01% | 2605 |
|
|
2025
Q1 | $24K | Buy |
1,933
+1,325
| +218% | +$22K | ﹤0.01% | 1965 |
|
|
2024
Q4 | $12K | Sell |
608
-54
| -8% | -$1.05K | ﹤0.01% | 2361 |
|
|
2024
Q3 | $13.4K | Buy |
662
+21
| +3% | +$429 | ﹤0.01% | 2126 |
|
|
2024
Q2 | $15K | Sell |
641
-286
| -31% | -$7.49K | ﹤0.01% | 2049 |
|
|
2024
Q1 | $24.3K | Sell |
927
-52
| -5% | -$1.48K | ﹤0.01% | 1662 |
|
|
2023
Q4 | $30.9K | Sell |
979
-50
| -5% | -$1.36K | ﹤0.01% | 1400 |
|
|
2023
Q3 | $28.9K | Sell |
1,029
-467
| -31% | -$16K | ﹤0.01% | 1328 |
|
|
2023
Q2 | $55.2K | Buy |
1,496
+31
| +2% | +$946 | ﹤0.01% | 1096 |
|
|
2023
Q1 | $43.9K | Buy |
1,465
+9
| +0.6% | +$296 | ﹤0.01% | 1115 |
|
|
2022
Q4 | $44.6K | Buy |
1,456
+25
| +2% | +$750 | ﹤0.01% | 1055 |
|
|
2022
Q3 | $35K | Sell |
1,431
-426
| -23% | -$14.1K | ﹤0.01% | 1082 |
|
|
2022
Q2 | $59K | Sell |
1,857
-2,367
| -56% | -$87.1K | ﹤0.01% | 846 |
|
|
2022
Q1 | $133K | Buy |
4,224
+123
| +3% | +$3.85K | ﹤0.01% | 649 |
|
|
2021
Q4 | $138K | Buy |
4,101
+131
| +3% | +$4.08K | ﹤0.01% | 609 |
|
|
2021
Q3 | $115K | Buy |
3,970
+369
| +10% | +$11.9K | ﹤0.01% | 583 |
|
|
2021
Q2 | $125K | Sell |
3,601
-715
| -17% | -$23.7K | ﹤0.01% | 446 |
|
|
2021
Q1 | $120K | Buy |
4,316
+3,665
| +563% | +$97.5K | ﹤0.01% | 425 |
|
|
2020
Q4 | $16K | Buy |
651
+100
| +18% | +$2.38K | ﹤0.01% | 717 |
|
|
2020
Q3 | $12K | Hold |
551
| – | – | ﹤0.01% | 663 |
|
|
2020
Q2 | $8K | Sell |
551
-2,000
| -78% | -$25.3K | ﹤0.01% | 765 |
|
|
2020
Q1 | $23K | Buy |
2,551
+1,984
| +350% | +$28.6K | ﹤0.01% | 533 |
|
|
2019
Q4 | $10K | Buy |
567
+80
| +16% | +$1.33K | ﹤0.01% | 643 |
|
|
2019
Q3 | $7K | Hold |
487
| – | – | ﹤0.01% | 626 |
|
|
2019
Q2 | $12K | Buy |
487
+4
| +0.8% | +$118 | ﹤0.01% | 541 |
|
|
2019
Q1 | $18K | Buy |
483
+3
| +0.6% | +$109 | ﹤0.01% | 469 |
|
|
2018
Q4 | $14K | Hold |
480
| – | – | ﹤0.01% | 463 |
|
|
2018
Q3 | $19K | Buy |
480
+16
| +3% | +$700 | ﹤0.01% | 438 |
|
|
2018
Q2 | $21K | Hold |
464
| – | – | ﹤0.01% | 401 |
|
|
2018
Q1 | $23K | Hold |
464
| – | – | ﹤0.01% | 354 |
|
|
2017
Q4 | $23K | Hold |
464
| – | – | ﹤0.01% | 355 |
|
|
2017
Q3 | $23K | Sell |
464
-80
| -15% | -$3.77K | ﹤0.01% | 343 |
|
|
2017
Q2 | $21K | Hold |
544
| – | – | ﹤0.01% | 366 |
|
|
2017
Q1 | $21K | Hold |
544
| – | – | ﹤0.01% | 351 |
|
|
2016
Q4 | $12K | Hold |
544
| – | – | ﹤0.01% | 374 |
|
|
2016
Q3 | $9K | Hold |
544
| – | – | ﹤0.01% | 424 |
|
|
2016
Q2 | $4K | Sell |
544
-45
| -8% | -$401 | ﹤0.01% | 479 |
|
|
2016
Q1 | $4K | Sell |
589
-21
| -3% | -$106 | ﹤0.01% | 470 |
|
|
2015
Q4 | $3K | Buy |
610
+80
| +15% | +$511 | ﹤0.01% | 496 |
|
|
2015
Q3 | $3K | Buy |
+530
| New | +$5.55K | ﹤0.01% | 489 |
|
Other funds holding CC
CCPM
Allworth Financial's CC Position: Q2 2026 in Review
Allworth Financial reduced its Chemours (CC) stake by 3.4% in Q2 2026, selling an estimated $2.02K and leaving 2,494 shares worth $51.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2463.
Allworth Financial first reported a position in CC in Q3 2015 and has held it in 44 quarters since. The position peaked at $138K in Q4 2021. 469 funds tracked by Wall St. Rank hold CC as of Q2 2026.
- Allworth Financial held 2,494 shares of Chemours worth $51.2K as of Q2 2026.
- Allworth Financial sold 88 Chemours shares in Q2 2026, an estimated $2.02K.
- Chemours made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #2463 holding.
- Allworth Financial first reported a position in Chemours in Q3 2015 and has held it in 44 quarters since.
- Allworth Financial's Chemours position peaked at $138K in Q4 2021.
- 469 funds tracked by Wall St. Rank held Chemours as of Q2 2026.
Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.